Philip Morris International Inc. is an international tobacco company. The Company's product portfolio primarily consists of cigarettes and smoke-free products, which include heat-not-burn, vapor, and oral nicotine products. The Company’s segments include Europe Region; South and Southeast Asia, Commonwealth of Independent States, Middle East and Africa Region (SSEA, CIS & MEA); East Asia, Australia, and PMI Duty Free Region (EA, AU & PMI DF); Americas Region; Swedish Match, and Wellness and Healthcare (W&H), which includes the operating of Vectura Fertin Pharma business.
The Company's brands include Marlboro, HEETS, IQOS, IQOS ILUMA, TEREA, and ZYN. The Company’s IQOS smoke-free product brand portfolio includes heated tobacco and nicotine-containing vapor products. Its smoke-free platform (Platform 1) uses a precisely controlled heating device into which a specially designed and proprietary tobacco unit is inserted and heated to generate an aerosol..
Price and Volume | |
---|---|
Volume | |
Ten Day Average Volume | 3.9M |
Three Month Average Volume | 102.4M |
High Low | |
Fifty-Two Week High | 123.45 USD |
Fifty-Two Week Low | 87.23 USD |
Fifty-Two Week High Date | 30 Aug 2024 |
Fifty-Two Week Low Date | 27 Oct 2023 |
Price and Volume | |
Current Price | 123.29 USD |
Beta | 1 |
Relative Price Change | |
Four Week Relative Price Change | -0.95% |
Thirteen Week Relative Price Change | 13.63% |
Twenty-Six Week Relative Price Change | 24.82% |
Fifty-Two Week Relative Price Change | 2.43% |
Year-to-Date Relative Price Change | 10.66% |
Price Change | |
One Day Price Change | 0.60% |
Thirteen Week Price Change | 21.61% |
Twenty-Six Week Price Change | 37.25% |
Five Day Price Change | 2.61% |
Fifty-Two Week Price Change | 28.35% |
Year-to-Date Price Change | 31.05% |
Month-to-Date Price Change | 7.06% |
Per Share Data | |
---|---|
Book Value | |
Book Value Per Share (Last Fiscal Year) | -7.23063 USD |
Book Value Per Share (Most Recent Quarter) | -6.26722 USD |
Tangible Book Value Per Share (Last Fiscal Year) | -24.39281 USD |
Tangible Book Value Per Share (Most Recent Quarter) | -24.91323 USD |
EBITD | |
EBITD Per Share (Trailing Twelve Months) | 9.3863 USD |
Revenue | |
Revenue Per Share (Last Fiscal Year) | 22.70058 USD |
Revenue Per Share (Trailing Twelve Months) | 23.44741 USD |
Dividend | |
Dividend Per Share (Last Fiscal Year) | 5.11 USD |
Dividend Per Share (Trailing Twelve Months) | 5.17 USD |
Dividend Per Share (5 Year) | 4.856 USD |
Earnings Per Share | |
Excluding Extraordinary Items (Last Fiscal Year) | 5.01674 USD |
Excluding Extraordinary Items (Trailing Twelve Months) | 5.64797 USD |
Normalized (Last Fiscal Year) | 5.65847 USD |
Basic Excluding Extraordinary Items (Last Fiscal Year) | 5.01997 USD |
Basic Excluding Extraordinary Items (Trailing Twelve Months) | 5.65336 USD |
Including Extraordinary Items (Last Fiscal Year) | 5.01674 USD |
Including Extraordinary Items (Trailing Twelve Months) | 5.64797 USD |
Cash | |
Cash Per Share (Last Fiscal Year) | 1.97111 USD |
Cash Per Share (Most Recent Quarter) | 3.0918 USD |
Cash Flow Per Share (Last Fiscal Year) | 6.15454 USD |
Cash Flow Per Share (Trailing Twelve Months) | 6.24574 USD |
Free Cash Flow Per Share (Trailing Twelve Months) | 1.32326 USD |
Margins | |
---|---|
Cash Flow Revenue | |
Cash Flow Revenue (5 Year) | 6 |
Cash Flow Revenue (Trailing Twelve Months) | 6 |
Pretax Margin | |
Pretax Margin (Trailing Twelve Months) | 31.66% |
Pretax Margin (Last Fiscal Year) | 29.64% |
Pretax Margin (5 Year) | 35.14% |
Gross Margin | |
Gross Margin (Last Fiscal Year) | 63.52% |
Gross Margin (Trailing Twelve Months) | 63.92% |
Gross Margin (5 Year) | 65.46% |
Operating Margin | |
Operating Margin (Last Fiscal Year) | 32.78% |
Operating Margin (Trailing Twelve Months) | 34.97% |
Operating Margin (5 Year) | 37.58% |
Net Profit Margin | |
Net Profit Margin (Last Fiscal Year) | 23.01% |
Net Profit Margin (Trailing Twelve Months) | 24.09% |
Net Profit Margin (5 Year) | 27.54% |
Growth | |
---|---|
Book Value | |
Book Value Per Share (5 Year) | -99,999.99% |
Tangible Book Value (5 Year) | -99,999.99% |
Free Operating Cash Flow | |
Free Operating Cash Flow (5 Year) | -99,999.99% |
Revenue | |
Revenue Change MRQ vs 1 Year Ago | 5.59% |
Revenue Growth (3 Year) | 3.54% |
Revenue Change (Trailing Twelve Months) | 9.62% |
Revenue Per Share Growth | 3.57% |
Revenue Growth (5 Year) | 7.10% |
Capital Spending Debt | |
Capital Spending (5 Year) | -1.66% |
Total Debt (5 Year) | 8.57% |
Dividends | |
Dividend Growth (3 Year) | 2.75% |
Earnings Per Share | |
EPS Change MRQ vs 1 Year Ago | 53.19% |
EPS Change (Trailing Twelve Months) | 9.26% |
EPS Growth (3 Year) | -0.32% |
EPS Growth (5 Year) | -0.92% |
EBITDA | |
EBITDA (5 Year) | 2.93% |
EBITDA (5 Year Interim) | 3.07% |
Net Profit Margin | |
Net Profit Margin Growth (5 Year) | -3.76% |
Valuation | |
---|---|
Total Price to Book | |
Price to Tangible Book (Last Fiscal Year) | -100,000 |
Price to Tangible Book (Most Recent Quarter) | -100,000 |
Price to Free Cash Flow | |
Price to Free Cash Per Share (Last Fiscal Year) | -100,000 |
Price to Free Cash Per Share (Trailing Twelve Months) | 93 |
Net Debt | |
Net Debt (Most Recent Quarter) | 44.3B |
Net Debt (Last Fiscal Year) | 44.8B |
Price to Sales | |
Price to Sales (Last Fiscal Year) | 5 |
Price to Sales (Trailing Twelve Months) | 5 |
Price to Earnings | |
PE Excluding Extraordinary Items (Last Fiscal Year) | 22 |
PE Normalized (Last Fiscal Year) | 22 |
PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | 18 |
PE Excluding Extraordinary Items High (Trailing Twelve Months) | 19 |
PE Excluding Extraordinary Items Low (Trailing Twelve Months) | 15 |
PE Including Extraordinary Items (Trailing Twelve Months) | 22 |
Dividends | |
Dividend Yield (5 Year) | 5.30% |
Dividend Yield | 4.22% |
Current Dividend Yield | 4.19% |
Price to Book | |
Price to Book (Last Fiscal Year) | -100,000 |
Price to Book (Most Recent Quarter) | -100,000 |
Financial Strength | |
---|---|
Debt to Equity | |
Long Term Debt to Equity (Last Fiscal Year) | -100,000 |
Long Term Debt to Equity (Most Recent Quarter) | -100,000 |
Payout Ratio | |
Payout Ratio (Last Fiscal Year) | 102.84% |
Payout Ratio (Trailing Twelve Months) | 92.43% |
Quick Ratio | |
Quick Ratio (Last Fiscal Year) | 0 |
Quick Ratio (Most Recent Quarter) | 1 |
Enterprise Value | |
Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | 873 |
Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | 1.4K |
Current Ratio | |
Current Ratio (Last Fiscal Year) | 1 |
Current Ratio (Most Recent Quarter) | 1 |
Free Cash Flow | |
Free Cash Flow (Last Fiscal Year) | -81,000,000 |
Free Cash Flow (Trailing Twelve Months) | 2.1B |
Net Interest Coverage | |
Net Interest Coverage (Last Fiscal Year) | 12 |
Net Interest Coverage (Trailing Twelve Months) | 12 |
Total Debt to Equity | |
Total Debt to Equity (Last Fiscal Year) | -100,000 |
Total Debt to Equity (Most Recent Quarter) | -100,000 |
Management Effectiveness | |
---|---|
Return on Assets | |
Return on Assets (Last Fiscal Year) | 12.77% |
Return on Assets (Trailing Twelve Months) | 13.75% |
Return on Assets (5 Year) | 17.77% |
Return on Equity | |
Return on Equity (Last Fiscal Year) | -99,999.99% |
Return on Equity (Trailing Twelve Months) | -99,999.99% |
Return on Equity (5 Year) | -99,999.99% |
Return on Investment | |
Return on Investment (Last Fiscal Year) | 23.56% |
Return on Investment (Trailing Twelve Months) | 22.38% |
Return on Investment (5 Year) | 34.25% |